Stop Presenting at Health-Tech Buyers — Let Them Drive

Apparently, it’s not just me. I’m probably like most buyers of products or services, especially those in high tech. Watching a video of some other person using or demonstrating a product does nothing for me. It barely registers in my brain. I can’t see how it relates directly to me and my needs, wants, and desires. The same goes for other product “demonstration” tools – ones that mindlessly make you follow around a mouse click with some feature description that I may or may not care about. Just doesn’t work for me. I need to see, touch, feel, and do for a product to resonate. On my own, with no one watching.

As Confucius wisely stated, “I hear and I forget. I see and I remember. I do and I understand.”

There is a pattern that anyone who has sat on the buyer side of a health-tech procurement knows well. A vendor gets thirty minutes with your clinical informatics team, your IT director, and your VP of Operations. They open with a slide about the company’s founding year and market position. They pivot to a feature walkthrough in what is obviously a pristine demo environment — clean data, no legacy integrations, no patient name fields that don’t map to your EHR’s preferred format. By slide fourteen, your clinical informatics lead has stopped taking notes and started answering emails. That’s totally me, FWIW.

That is not a vendor problem. It is not giving healthcare buyers what they actually need.

Healthcare purchasing is almost unlike any other in enterprise software. The stakes are not abstract. Real people with real problems. A scheduling tool that does not account for care team handoff protocols creates patient safety gaps. A revenue cycle platform that cannot reconcile with your existing coding workflow does not save money; it generates audit risk. A patient engagement product that requires three IT ticket escalations to onboard a single department is not a digital transformation; it is another implementation project with six months of hoops to run through.

And yet most enterprise health-tech vendors still lead with the pitch.

The evaluation problem vendors keep ignoring

The average health-tech software evaluation involves somewhere between six and twelve stakeholders, depending on the system’s size and the product’s clinical exposure. You have clinicians who care whether the interface disrupts their documentation rhythm. You have compliance officers who want to know about data residency, audit trail depth, and HIPAA edge cases before they will let the product anywhere near a test environment. You have IT teams that have been burned by integrations that worked in the demo and broke in the pilot. And you have finance and operations leadership weighing the total cost of ownership against a budget set eighteen months ago.

A polished thirty-minute presentation does not answer what any of those people actually need to know. Free trials sometimes work well, but they leave much of the work to the prospect and don’t make it easy to truly experience your product.

By allowing prospects to see, touch, and interact with your products early in the sales process, you can achieve two key outcomes: 1) significantly shorten the sales cycle, and 2) efficiently identify prospects who are genuinely interested (and those that aren’t), all without involving your sales and solutions engineering teams until the prospect has expressed a clear interest.

This approach not only streamlines the sales process but also enhances engagement and understanding, ensuring that potential clients are well-informed and excited about your offerings.

What those stakeholders need is direct contact with the product — not a guided tour, but genuine exploration. They need to run a scenario that resembles a real Tuesday afternoon in their department. They need to hit the edge case, find the workflow gap, ask the question that was not on the pre-submitted list. The only way to know whether a scheduling product fits your staffing model is to try to build a schedule with it, using the shift rules your nursing director will insist on the moment you go live.

This is not a new insight. It is what every experienced health system buyer already knows. The problem is that for most of the last decade, the vendor side of the table has not caught up.

What is actually shifting — and why it matters now

Something is changing.  A colleague sent me this, and it really hit home:  The way B2B buyers evaluate software has shifted dramatically. According to Gartner’s 2025 sales survey, 61% of B2B buyers now prefer a completely rep-free buying experience. Buyers spend only 17% of their total buying time meeting with potential suppliers. The rest? They’re researching on their own.  61%. Big number.

This means your product demo often speaks for you before your sales team ever gets a chance. And if that demo is a clunky screen share recording or a 45-minute live walkthrough, you’re losing deals to competitors who figured out how to let their product sell itself.

The mechanism matters. When a buyer interacts with the actual product in an environment that approximates their operational context, two things happen simultaneously. First, they make faster, more accurate decisions about fit. Second, the vendor receives an honest signal about where the product falls short – before the contract is signed. That second part is uncomfortable for some sales organizations but is, in practice, a feature. A deal that closes on accurate expectations is worth considerably more than one that closes on a polished presentation and then churns twelve months into the contract.

Healthcare specifically rewards this kind of transparency. The organizations that buy software in this space are not naive purchasers. They can’t be. Chief Medical Officers have been oversold on technology for twenty years. They have lived through EHR implementations that consumed entire budget cycles and left clinical staff demoralized. They are skeptical by training. The fastest path to their confidence is not a sharper deck or a better reference customer list – it is direct, unscripted, hands-on product experience that respects their capacity to make their own assessment.

What the vendor side needs to internalize

Winning in health-tech is not about having the best feature set on paper. It is about giving buyers enough operational clarity, early enough, that they can say yes with confidence rather than saying yes because the alternative is another six months of the same evaluation cycle.

That means thinking carefully about how buyers encounter your product before the formal evaluation stage even begins. It means building evaluation experiences that can absorb real-world scenario testing, messy data, non-standard workflows, and the kinds of edge cases that do not appear in a structured demo. It means accepting that a buyer who finds a limitation in a pre-sales environment is a better-prepared customer, not a lost opportunity.

For health-tech vendors, the pressure to close this gap is only intensifying. Health systems are managing tighter operating margins, more demanding regulatory environments, and a workforce with limited tolerance for technology that creates friction rather than removes it. Buyers are getting more rigorous about evaluation, not less. The vendors who earn their way past the front door will increasingly be the ones who make it genuinely easy to know, before the ink is dry, whether the product works in the world as it actually exists, not the world as it appears in a demo environment.

That is a different kind of go-to-market capability than most health-tech vendors have built. It is also the one the market is moving toward. Whether vendors are ready or not.

Photo: ipopba, Getty Images

This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.